Latest Breaking News On - பிராங்க்ஃபர்ட் பெர்சே - Page 4 : comparemela.com

Share this article Share this article VANCOUVER, BC, June 28, 2021 /PRNewswire/ BioVaxys Technology Corp. (CSE: BIOV, FRA:5LB,OTCQB:BVAXF) ( BioVaxys or the Company ) is pleased to announce a non-brokered private placement (the Private Placement ) consisting of up to 9,090,909 units ( Units ) at a price of $0.22 per Unit for total gross proceeds of up to approximately $2,000,000. Each Unit consists of one common share (a Common Share ) and one whole Common Share purchase warrant (a Warrant ). Each Warrant is exercisable for one additional Common Share at an exercise price of $0.50 for a period of 30 months. All securities issued pursuant to the Private Placement are subject to a statutory hold period of four months and one day from the date of issuance. The Company may pay cash finder s fees on all or a portion of the Private Placement.

United statesUnited kingdomBritish columbiaNikita sachdevBiovaxys technology corpMedia contacts biovaxys technology corpPrnewswire biovaxys technology corpCanadian securities exchangeVaxys technologyCommon shareEach warrantPrivate placementBritish columbia registeredFrankfurt bourseஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்